Periostin levels and eosinophilic inflammation in poorly-controlled asthma

Item

http://www.wikidata.org/entity/Q36003967

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Periostin levels and eosinophilic inflammation in poorly-controlled asthma

@ast

Periostin levels and eosinophilic inflammation in poorly-controlled asthma

@en

type

Item

label

Periostin levels and eosinophilic inflammation in poorly-controlled asthma

@ast

Periostin levels and eosinophilic inflammation in poorly-controlled asthma

@en

prefLabel

Periostin levels and eosinophilic inflammation in poorly-controlled asthma

@ast

Periostin levels and eosinophilic inflammation in poorly-controlled asthma

@en

P1476

Periostin levels and eosinophilic inflammation in poorly-controlled asthma

@en

P2093

Alan L James

http://www.w3.org/2001/XMLSchema#string

Cecile T J Holweg

http://www.w3.org/2001/XMLSchema#string

Christine Jenkins

http://www.w3.org/2001/XMLSchema#string

Guiquan Jia

http://www.w3.org/2001/XMLSchema#string

Jodie L Simpson

http://www.w3.org/2001/XMLSchema#string

Paul N Reynolds

http://www.w3.org/2001/XMLSchema#string

Sandra Hodge

http://www.w3.org/2001/XMLSchema#string

P2860

Translational biomarker discovery in clinical metabolomics: an introductory tutorial

Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies.

Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma.

Lebrikizumab treatment in adults with asthma.

The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge.

Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients.

T-helper type 2-driven inflammation defines major subphenotypes of asthma.

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.

P2888

s12890-016-0230-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12890-016-0230-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1014869265

http://www.w3.org/2001/XMLSchema#string

P698

27130294

http://www.w3.org/2001/XMLSchema#string

P921

asthma

P932

4851782

http://www.w3.org/2001/XMLSchema#string